A proprietary multi-analyte test to predict neoadjuvant treatment response for esophageal and rectal adenocarcinoma patients.
Sunil S. Badve
No relevant relationships to disclose
Weiwei Shan
Employment or Leadership Position - Castle Biosciences
Clare Johnson
Employment or Leadership Position - Castle Biosciences
Stock Ownership - Castle Biosciences
Yaeli Biermann-Harrar
No relevant relationships to disclose
Kristen M. Oelschlager
Employment or Leadership Position - Castle Biosciences
Stock Ownership - Castle Biosciences
Derek Maetzold
Employment or Leadership Position - Castle Biosciences
Stock Ownership - Castle Biosciences
Kenneth Kessler
No relevant relationships to disclose
Romil Saxena
No relevant relationships to disclose
Daniel Rosen
No relevant relationships to disclose
Robert W. Cook
Employment or Leadership Position - Castle Biosciences
Stock Ownership - Castle Biosciences